Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Senseonics Holdings Inc
SENS | US
7.13
USD0.46
6.90%
SENS | US
Loading StockChartView...
About Senseonics Holdings Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
08/06/2026
Close
7.13
Open
6.84
High
7.35
Low
6.78
Senseonics Holdings Inc. a medical technology company develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States Europe the Middle East and Africa. The company's products include Eversense Eversense XL and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor a removable and rechargeable smart transmitter and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings Inc. was founded in 1996 and is headquartered in Germantown Maryland.
View LessSENS | US
Risk
76.1
Sharpe
-0.51
Luna's Score
52/100
Recommendation
Hold
Luna says (SENS | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
59.4%1 month
76.1%3 months
89.5%6 months
80.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
21.51
Price to book
329.13
Debt to equity
1.55
Debt to assets
0.53
Ent. to EBITDA
1.76
Ent. to rev.
6.86
PEG
-
Other Fundamentals
EBITDA
-72.41M
MarketCap
3.82B
MarketCap(USD)
3.82B
Div. yield
-
Op. margin
-400.68
Erngs. growth
-
Rev. growth
17.90
Ret. on equity
-125.30
Short ratio
7.51
Short perc.
10.03
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.20
Range1M
2.35
Range3M
2.66
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.11
Price X volume
5.12M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.76 | 12.67 | Cheaper |
| Ent. to Revenue | 6.86 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 329.13 | 77.50 | Expensive |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 89.46 | 59.59 | Riskier |
| Debt to Equity | 1.55 | -14.36 | Expensive |
| Debt to Assets | 0.53 | 0.34 | Expensive |
| Market Cap | 3.82B | 13.71B | Emerging |
